XBI: SPDR® S&P® Biotech ETF

Benchmark	Inception Date	Options Available	Gross Expense Ratio Gross Expense Ratio The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.	Base Currency	Investment Manager	Management Team
S&P Biotechnology Select Industry Index	Jan 31 2006	Yes	0.35%	USD	SSGA Funds Management, Inc.	Global Equity Beta Solutions

Exchange	Listing Date	Trading Currency	Ticker	CUSIP	ISIN
NYSE ARCA EXCHANGE	Feb 06 2006	USD	XBI	78464A870	US78464A8707

Est. 3-5 Year EPS Growth Estimated 3-5 Year EPS Growth Based on the underlying holdings of the fund. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate.	Number of Holdings	Price/Book Ratio Price/Book Ratio The weighted harmonic average of closing market price divided by the most recent reported book value for each security in the fund's portfolio as calculated for the last twelve months.	Price/Earnings Ratio FY1 Price/Earnings Ratio FY1 The weighted harmonic average of current share price divided by the forecasted one year earnings per share for each security in the fund. Negative and positive outliers are included in the calculation.	Weighted Average Market Cap
10.50%	133	5.49	12.01	$10,128.48 M

Est. 3-5 Year EPS Growth	Number of Holdings	Price/Cash Flow	Price/Earnings	Price/Earnings Ratio FY1
10.50%	132	17.19	17.62	12.01

	Average Size	Size Range
$10,125.70 M	$7,567.24 M	$1,709.96 M	$158,132.67 M	$158.09 M

30 Day SEC Yield 30 Day SEC Yield (Also known as Standardized Yield) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price.	30 Day SEC Yield (Unsubsidized) 30 Day SEC Yield (Unsubsidized) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price that does not account for expense ratio waivers.	Fund Dividend Yield Fund Dividend Yield The sum of the most recent 12 dividends within the past 365 days divided by Net Asset Value per share, expressed as a percentage.	Index Dividend Yield Index Dividend Yield The weighted average of the underlyings' indicated annual dividend divided by price, expressed as a percentage.
0.17%	-	0.02%	0.11%

Bid/Ask Bid/Ask Mid Point (Also known as Mid Price) The price between the best price of the sellers for a trading unit of a given security and the best price of the buyer of a trading unit of a given security.	Closing Price Closing Price Market Price of last reported trade on the exchange.	Day High	Day Low	Exchange Volume (Shares) Exchange Volume (shares) Represents the volume of shares traded on the ETF's primary exchange throughout the previous business day.	Premium/Discount Premium/Discount to NAV Shows the comparison of the daily net asset value (NAV) and the Midpoint of the closing bid/ask for each of the funds calculated as ((4PM Bid/Ask - Closing NAV) / Closing NAV * 100)
$115.08	$114.98	$115.79	$113.29	974,619	0.02%

Net Cash Amount
$719,654.54

	As Of	1 Month	QTD	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception Jan 31 2006
Fund Before Tax
NAV	Aug 31 2020	2.41%	-0.22%	17.40%	39.08%	10.13%	8.79%	20.78%	14.36%
Market Value	Aug 31 2020	2.32%	-0.20%	17.42%	39.14%	10.17%	8.80%	20.78%	14.37%
S&P Biotechnology Select Industry Index	Aug 31 2020	2.39%	-0.28%	17.41%	39.13%	10.16%	8.74%	20.61%	14.37%
Fund After Tax
Return after Taxes on Distributions	Aug 31 2020	2.41%	-0.22%	17.39%	39.07%	10.10%	8.71%	20.65%	14.25%
Return after Taxes on Distributions and Sale of Fund Shares	Aug 31 2020	1.42%	-0.13%	10.30%	23.13%	7.88%	6.91%	18.00%	12.51%
S&P Biotechnology Select Industry Index	Aug 31 2020	2.39%	-0.28%	17.41%	39.13%	10.16%	8.74%	20.61%	14.37%

	As Of	1 Month	QTD	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception Jan 31 2006
Fund Before Tax
NAV	Jun 30 2020	8.07%	44.42%	17.66%	27.59%	13.36%	6.12%	20.92%	14.56%
Market Value	Jun 30 2020	8.22%	44.72%	17.65%	27.66%	13.35%	6.12%	20.92%	14.56%
S&P Biotechnology Select Industry Index	Jun 30 2020	8.09%	44.50%	17.74%	27.70%	13.38%	6.07%	20.77%	14.57%
Fund After Tax
Return after Taxes on Distributions	Jun 30 2020	8.07%	44.41%	17.65%	27.58%	13.32%	6.05%	20.79%	14.45%
Return after Taxes on Distributions and Sale of Fund Shares	Jun 30 2020	4.78%	26.30%	10.46%	16.33%	10.46%	4.76%	18.13%	12.68%
S&P Biotechnology Select Industry Index	Jun 30 2020	8.09%	44.50%	17.74%	27.70%	13.38%	6.07%	20.77%	14.57%

Name	Shares Held	Total Mkt Cap M	Weight
Immunomedics Inc.	1,991,125	$19,726.91	2.66%
Novavax Inc.	1,350,723	$7,078.24	2.44%
Invitae Corp.	3,807,015	$5,158.27	2.33%
Aimmune Therapeutics Inc	3,240,235	$2,244.29	1.74%
Momenta Pharmaceuticals Inc.	1,983,162	$6,225.45	1.62%
SAGE Therapeutics Inc.	1,700,871	$3,123.65	1.60%
Mirati Therapeutics Inc.	601,627	$7,214.26	1.53%
Natera Inc.	1,504,432	$5,122.28	1.44%
Emergent BioSolutions Inc.	895,280	$5,378.76	1.42%
TG Therapeutics Inc.	3,582,726	$3,171.30	1.40%

Name	Total Mkt Cap M	Weight
Immunomedics Inc.	$19,726.91	2.66%
Novavax Inc.	$7,078.24	2.44%
Invitae Corp.	$5,158.27	2.33%
Aimmune Therapeutics Inc	$2,244.29	1.74%
Momenta Pharmaceuticals Inc.	$6,225.45	1.62%
SAGE Therapeutics Inc.	$3,123.65	1.60%
Mirati Therapeutics Inc.	$7,214.26	1.52%
Natera Inc.	$5,122.28	1.43%
Emergent BioSolutions Inc.	$5,378.76	1.42%
TG Therapeutics Inc.	$3,171.30	1.40%

Sector	Weight
Biotechnology	100.00%

Sector	Weight
Biotechnology	100.00%

In general, ETFs can be expected to move up or down in value with the value of the applicable index. Although ETF shares may be bought and sold on the exchange through any brokerage account, ETF shares are not individually redeemable from the Fund. Investors may acquire ETFs and tender them for redemption through the Fund in Creation Unit Aggregations only. Please see the prospectus for more details.

After-tax returns are calculated based on NAV using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

Unless Otherwise noted all information contained herein is that of the SPDR S&P Biotech ETF.

Performance of an index is not illustrative of any particular investment. It is not possible to invest directly in an index.

Holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future.

As with all stocks, you may be required to deposit more money or securities into your margin account if the equity, including the amount attributable to your ETF shares, declines.

The S&P Select Industry series is designed to measure the performance of narrow GICS (Global Industry Classification Standard) sub-industries. The S&P Biotech Select Industry Index is an equal-weighted index that draws constituents from the Biotechnology segment of the S&P TMI. Liquidity and market capitalization screens are applied to the index to ensure investability.

Distributor	State Street Global Advisors Funds Distributors, LLC
Distribution Frequency	Quarterly

NAV NAV The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.	$115.06
Shares Outstanding	54.68 M
Assets Under Management	$6,291.06 M

SPDR® S&P® Biotech ETF XBI

Important Risk Disclosure

Key Features

About this Benchmark

Fund Information as of Sep 17 2020

Listing Information as of Sep 17 2020

Fund Characteristics as of Sep 17 2020

Index Characteristics as of Sep 17 2020

Index Statistics as of Sep 17 2020

Yields as of Sep 17 2020

Fund Market Price as of Sep 17 2020

Premium Discount to Nav

Fund Net Cash Amount as of Sep 17 2020

Fund Net Asset Value as of Sep 17 2020

Fund Performance

Top Holdings
Subject to change.

Fund Top Holdings as of Sep 17 2020

Index Top Holdings as of Sep 17 2020

Sub-Industry Allocation

Fund Sub-Industry Allocation as of Sep 17 2020

Index Sub-Industry Allocation as of Sep 17 2020

Purchase Information

	Average Size		Size Range
Weighted Average Market Cap	Mean	Median	Largest	Smallest
$10,125.70 M	$7,567.24 M	$1,709.96 M	$158,132.67 M	$158.09 M